GCTK - GlucoTrack, Inc. Stock Analysis

Stock Taper

SCREENER COMPARE ANY 2 STOCKS

GCTK

GLUCOTRACK, INC.

NASDAQ

$0.28

▼ DOWN 1.47% (-0.00)

KEY STATISTICS

Market Cap$2.18 M

52w High$14.14

52w Low$0.25

Dividend Yield—

Frequency—

P/E-0.01

Volume2.53M

Shares Out.7.72M

COMPANY

LEADERSHIP

CHIEF EXECUTIVE

Erik Emerson

COMPENSATION 2026

Salary$350,000

Stock Awards$0

Incentive Plan Pay$0

All Other Comp.$0

Total$350,000

ABOUT

SECTOR

Healthcare

WENT PUBLIC

April 25, 2013

METHOD OF GOING PUBLIC

N/A

FULL TIME EMPLOYEES

SPLIT RECORD

DATE	TYPE	RATIO
2026-08-31	Reverse	1:15
2025-06-16	Reverse	1:60
2024-05-20	Reverse	1:5
2021-08-13	Reverse	1:13

PRICE

$0.28 ▼ DOWN 1.47% (−$0.00)

OVERLAYS

About GlucoTrack, Inc.

https://www.glucotrack.com ↗

GlucoTrack, Inc. designs and commercializes non-invasive glucose monitoring devices for diabetics and pre-diabetics worldwide, offering pain-free blood glucose readings, and is based in Or Yehuda, Israel.

INDUSTRY

Medical - Instruments & Supplies

A PRODUCT GLUCOTRACK, INC. IS KNOWN FOR

Implantable Continuous Blood Glucose Monitor (CBGM)

A long-term implantable system for diabetes patients that continuously monitors blood glucose levels directly from blood for up to three years, eliminating lag time and reducing daily management burden.